XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating Activities    
Net income $ 154,777 $ 63,940
Items not requiring (providing) cash:    
Depreciation and amortization 15,187 16,439
Amortization of premiums and discounts 18,844 28,454
Deferred income taxes 11,643 (3,868)
Increase in cash surrender value of bank-owned life insurance (27,426) (27,366)
Changes in:    
Accrued interest receivable (101,582) (47,136)
Other assets and liabilities 1,057,006 101,765
Net cash provided by operating activities 1,128,449 132,228
Investing Activities    
Net change in interest-bearing time deposits 490,000 735,000
Purchases of available-for-sale securities (17,251,471) (2,602,262)
Proceeds from calls, maturities and paydowns of available-for-sale securities 570,021 1,848,978
Net change in loans (1,387,960) (1,629,779)
Purchase of premises and equipment   (9,965)
Proceeds from redemption of FHLB stock 344,200  
Net cash used in investing activities (17,235,210) (1,658,028)
Financing Activities    
Net increase (decrease) in deposit accounts (4,030,181) 538,003
Net change in advances by borrowers for taxes and insurance (141,822) (134,743)
Proceeds from issuance of common stock 1,011,257  
Net cash provided by (used in) financing activities (3,160,746) 403,260
Decrease in Cash and Cash Equivalents (19,267,507) (1,122,540)
Cash and Cash Equivalents, Beginning of Period 36,711,842 11,660,839
Cash and Cash Equivalents, End of Period 17,444,335 10,538,299
Cash paid during the period for:    
Interest on deposits and borrowings 71,888 $ 94,565
Supplemental Disclosure of Noncash Financing Activities    
Transfers from stock subscriptions to common stock and additional paid-in capital $ 15,315,230